Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00017472
Status:
COMPLETED
Last Update Posted:
2013-06-04
First Post:
2001-06-06
Brief Title:
Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia Lymphocytic Lymphoma Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Small Lymphocytic Lymphoma |
| Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue |
| Nodal Marginal Zone B-cell Lymphoma |
| Noncontiguous Stage II Marginal Zone Lymphoma |
| Noncontiguous Stage II Small Lymphocytic Lymphoma |
| Recurrent Adult Acute Lymphoblastic Leukemia |
| Recurrent Adult Acute Myeloid Leukemia |
| Recurrent Marginal Zone Lymphoma |
| Recurrent Small Lymphocytic Lymphoma |
| Refractory Chronic Lymphocytic Leukemia |
| Splenic Marginal Zone Lymphoma |
| Stage III Marginal Zone Lymphoma |
| Stage III Small Lymphocytic Lymphoma |
| Stage IV Marginal Zone Lymphoma |
Keywords: